The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
July 7th 2025
The new formulation contains little IgA, reducing possible risks associated with infusion in patients with primary immunodeficiency.
FDA Approves Expanded Use for Biologic Autoinflammatory Disease Drug
October 17th 2016Ilaris is the first FDA-approved biologic treatment for Tumor Necrosis Factor–Receptor Associated Periodic Syndrome, Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency and Familial Mediterranean Fever.
Read More